Indian Journal of Medical Biochemistry

Register      Login

VOLUME 21 , ISSUE 2 ( July-December, 2017 ) > List of Articles


Role of Active Vitamin D3 in Immunity

Rashmi Verma, Sapna Singh, Bhawna Singh, Binita Goswami, Santosh K Gupta

Citation Information : Verma R, Singh S, Singh B, Goswami B, Gupta SK. Role of Active Vitamin D3 in Immunity. Indian J Med Biochem 2017; 21 (2):166-175.

DOI: 10.5005/jp-journals-10054-0043

License: NA

Published Online: 01-12-2017

Copyright Statement:  NA



The active vitamin D3—1,25 dihydroxy cholecalciferol—is the key player in calcium and phosphorus metabolism and skeletal growth and functions. However, recent new developments have revealed its role in other tissues as well, referred to as the nonclassical actions of vitamin D. Not only the endocrinal effects, evidence indicates that vitamin D3 also has autocrine and paracrine functions due to its extrarenal synthesis by many cells, including the immune cells. All cells of the immune system have vitamin D receptors and show wide-ranging effects to it. It impacts both the innate and adaptive immune systems and the overall influence points to anti-infective, anti-inflammatory, immunosuppressive, and regulatory roles. It shows a significant role in chronic inflammatory and autoimmune diseases as well in susceptibility to infections.

In this review, newer developments on the role of vitamin D in immunity and the underlying mechanism are discussed with possible future reflections.

How to cite this article

Verma R, Singh S, Singh B, Goswami B, Gupta SK. Role of Active Vitamin D3 in Immunity. Indian J Med Biochem 2017;21(2):166-175.

  1. Vitamin D in autoimmunity: molecular mechanisms and therapeutic potential. Front Immunol 2016;7:697.
  2. Vitamin D3: a helpful immuno-modulator. Immunology 2011 Oct;134(2):123-139.
  3. Long-term vitamin D3 supplementation is more effective than vitamin D2 in maintaining serum 25-hydroxyvitamin D status over the winter months. Br J Nutr 2013 Mar;109(6):1082-1088.
  4. Vitamin D metabolism and function in the skin. Mol Cell Endocrinol 2011 Dec;347(1-2):80-89.
  5. 1α, 25(OH)2D3-induced DNA methylation suppresses the human CYP27B1 gene. Mol Cell Endocrinol 2007 Feb;265-266:168-173.
  6. Inhibition of p38 MAP kinase activity up-regulates multiple MAP kinase pathways and potentiates 1,25-dihydroxyvitamin D(3)-induced differentiation of human leukemia HL60 cells. Exp Cell Res 2000 Aug;258(2):425-437.
  7. Evidence for auto/paracrine actions of vitamin D in bone: 1 α-hydroxylase expression and activity in human bone cells. FASEB J 2006 Nov;20(13):2417-2419.
  8. Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor. Mol Endocrinol 2002 Aug;16(8):1738-1751.
  9. 1,25-dihydroxy1,25(OH)2D3 receptors in human leukocytes. Science 1983 Sep;221(4616):1181-1183.
  10. Down-regulation of NF-κB signals is involved in loss of 1α, 25-dihydroxyvitamin responsiveness. J Steroid Biochem Mol Biol 2010 Mar;120(1):11-21.
  11. 1,25 dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis. Lancet 1979 Mar;1(8117):627-630.
  12. Extra-renal 25-hydroxy1,25(OH)2D3-1α-hydroxylase in human health and disease. J Steroid Biochem Mol Biol 2007 Mar;103(3-5):316-321.
  13. Immune regulation of 25-hydroxyvitamin-D-3-1 α-hydroxylase in human monocytes. J Bone Miner Res 2006 Jan;21(1):37-47.
  14. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2002 Jul;76(1):187-192.
  15. 1,25(OH)2D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 2006 Feb;36(2):361-370.
  16. Direct and indirect induction by 1,25-dihydroxy1,25(OH)2 D3 of the NOD2/CARD15-defensin β2 innate immune pathway defective in Crohn disease. J Biol Chem 2010;285:2227-2231.
  17. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol 2008 Nov;181(10):7115-7120.
  18. Alternative splicing of vitamin D-24-hydroxylase: a novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis. J Biol Chem 2005 May;280(21):20604-20611.
  19. 1α,25-dihydroxy1,25(OH)2D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection. Immunology 2009 Aug;127(4):539-548.
  20. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxy1,25(OH)2D3. FASEB J 2005 Jul;19(9):1067-1077.
  21. 1,25-Dihydroxy1,25(OH)2D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Inf Immun 1998 Nov;66(11):5314-5321.
  22. Tolerogenic dendritic cells. Annu Rev Immunol 2003;21:685-711.
  23. 1,25(OH)2D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 2000 May;164(9):4443-4451.
  24. The Vitamin D3 analog calcipotriol suppresses the number and antigen-presenting function of Langerhans cells in normal human skin. J Investig Dermatol Symp Proc 1996 Apr;1(1):72-77.
  25. Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. Hum Immunol 2009 May;70(5):345-352.
  26. Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter. Proc Natl Acad Sci U S A 2005 Nov;102(44):16007-16012.
  27. Modulatory effects of 1,25-dihydroxy1,25(OH)2D3 on human B cell differentiation. J Immunol 2007 Aug;179(3):1634-1647.
  28. 1a,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Investig 1984 Aug;74(2):657-661.
  29. B cell abnormalities in systemic lupus erythematosus. Arthritis Res Ther 2003 Dec;5(Suppl 4):S22-S27.
  30. Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system. J Steroid Biochem Mol Biol 2010 Jul;121(1-2):221-227.
  31. The anti-inflammatory effects of 1,25-dihydroxy1,25(OH)2D3 on Th2 cells in vivo are due in part to the control of integrin mediated T lymphocyte homing. Eur J Immunol 2004;34:1068-1076.
  32. The targets of vitamin D depend on the differentiation and activation status of CD4-positive T cells. J Cell Biochem 2003 Aug;89(5):922-932.
  33. 1,25-Dihydroxy1,25(OH)2D3 modulated cytokine response in pulmonary tuberculosis. Cytokine 2007 Oct;40(2):128-134.
  34. Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands. J Steroid Biochem Mol Biol 2004 May;89-90(1-5):437-441.
  35. Vitamin D and 1,25(OH)2D Regulation of T cells. Nutrients 2015 Apr;7(4):3011-3021.
  36. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 2009 Aug;58(8):1152-1167.
  37. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010 Mar;129(3):311-321.
  38. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005 Jan;201(2):233-240.
  39. 1,25-dihydroxyvitamin D3 modulates cytokine production induced by Candida albicans: impact of seasonal variation of immune responses. J Infect Dis 2011 Jan;203(1):122-130.
  40. 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum 2010 Jan;62(1):132-142.
  41. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008 Jan;324(1):23-33.
  42. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008 May;453(7192):236-240.
  43. Induction and molecular signature of pathogenic TH17 cells. Nat Immunol 2012 Oct;13(10):991-999.
  44. α,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells. Immunol Lett 2010 Nov;134(1):7-16.
  45. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain 2009 May;132(Pt 5):1146-1160.
  46. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One 2009 Aug;4:e6635.
  47. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010 Jan;11(1):7-13.
  48. Development and maintenance of regulatory T cells. Immunity 2013 Mar;38(3):414-423.
  49. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1phenotype. Nature 2003 Jan;421(6921):388-392.
  50. Regulation of cutaneous immunity by the environment: an important role for UV irradiation and vitamin D. Int Immunopharmacol 2009 May;9(5):587-589.
  51. Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J Immunol 2009 May;182(10):6071-6078.
  52. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008 Apr;28(4):546-558.
  53. The molecular basis of IL-10 function: from receptor structure to the onset of signaling. Curr Top Microbiol Immunol 2014;380:191-212.
  54. 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. Eur J Immunol 2011 Mar;41(3):822-832.
  55. Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects. J Immunol 2010 Oct;185(8):4948-4958.
  56. 1a, 25-dihydroxyvitamin D3 in combination with transforming growth factor-b increases the frequency of Foxp3(+) regulatory T cells through preferential expansion and usage of interleukin-2. Immunology 2014 Sep;143(1):52-60.
  57. Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis. J Neuroimmunol 2009 Aug;213(1-2):135-141.
  58. Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis. J Steroid Biochem Mol Biol 2010 Jul;121(1-2):243-246.
  59. Correlation between the cord vitamin D levels and regulatory T cells in newborn infants. Eur J Pediatr 2012 Aug;171(8):1161-1166.
  60. CD8(+) T cells: foot soldiers of the immune system. Immunity 2011 Aug;35(2):161-168.
  61. Vitamin D receptor expression controls proliferation Of naïve CD8+ T cells and development of CD8 mediated gastrointestinal inflammation. BMC Immunol 2014 Feb;15:6.
  62. Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects. J Neuroimmunol 2011 Apr;233(1-2):240-244.
  63. The vitamin D analogue calcipotriol reduces the frequency of CD8+ IL-17+ T cells in psoriasis lesions. Scand J Immunol 2015 Jul;82(1):84-91.
  64. Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression. Arthritis Rheumatol 2014 May;66(5):1272-1281.
  65. The burgeoning family of unconventional T cells. Nat Immunol 2015 Nov;16(11):1114-1123.
  66. Gammadelta T cells and NK cells-distinct pathogenic roles as innate-like immune cells in CNS autoimmunity. Front Immunol 2015 Sep;6:455.
  67. Transcriptional profiling of gamma delta T cells identifies a role for vitamin D in the immunoregulation of the V gamma 9V delta 2 response to phosphate-containing ligands. J Immunol 2005 May;174(10):6144-6152.
  68. NKT cells can help mediate the protective effects of 1,25-dihydroxyvitamin D3 in experimental autoimmune encephalomyelitis in mice. Int Immunol 2015 May;27(5):237-244.
  69. The vitamin D receptor is required for iNKT cell development. Proc Natl Acad Sci U S A 2008 Apr;105(13):5207-5212.
  70. NK cell autoreactivity and autoimmune diseases. Front Immunol 2014 Feb;5:27.
  71. 1,25-Dihydroxy-vitamin D3 regulates NK-cell cytotoxicity, cytokine secretion, and degranulation in women with recurrent pregnancy losses. Eur J Immunol 2015 Nov;45(11):3188-3199.
  72. Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. J Invest Dermatol 2014 Apr;134(4):984-991.
  73. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med 2011 Jun;208(6):1127-1133.
  74. Inhibition of LTi cell development by CD25 blockade is associated with decreased intrathecal inflammation in multiple sclerosis. Sci Trans Med 2012 Aug;4(145):145ra06.
  75. The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjogren's syndrome. Expert Rev Clin Immunol 2014 Apr;10(4):533-541.
  76. Cutting edge: vitamin D mediated human antimicrobial activity against Mycobacterium tuberculosisis dependent on the induction of cathelicidin. J Immunol 2007 Aug;179(4):2060-2063.
  77. Defensins and cathelicidins in gastrointestinal infections. Curr Opin Gastroenterol 2007 Jan;23(1):32-38.
  78. 1,25(OH)2D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009 Sep;6(3):231-243.
  79. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). J Cyst Fibros 2007 Nov;6(6):403-410.
  80. Epidemic influenza and vitamin D. Epidemiol Infect 2006 Dec;134(6):1129-1140.
  81. High frequency of vitamin D deficiency in ambulatory HIV-positive patients. AIDS Res Hum Retroviruses 2009 Jan;25(1):9-14.
  82. The effect of 1,25-1,25(OH)2D3 on maturation of monocytes from HIV-infected patients varies with degree of immunodeficiency. APMIS 1996;104:539-548.
  83. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009 Apr;7:28.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.